Several studies have shown that BACE1 levels and its proteolytic activity are increased in postmortem AD brain samples (Fukumoto et al., 2002; Holsinger et al., 2002; Zhao et al., 2007). This evidence concerns the gene BACE1 and Alzheimer disease.